Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Senestech, Inc. (SNES : NSDQ)
 
 • Company Description   
SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona.

Number of Employees: 27

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.48 Daily Weekly Monthly
20 Day Moving Average: 46,635 shares
Shares Outstanding: 12.21 (millions)
Market Capitalization: $5.86 (millions)
Beta: 1.38
52 Week High: $1.92
52 Week Low: $0.39
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -25.09% -15.64%
12 Week -35.90% -29.54%
Year To Date -50.95% -37.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
23460 NORTH 19TH AVENUE SUITE 110
-
PHOENIX,AZ 85027
USA
ph: 928-779-4143
fax: -
senestech@lythampartners.com http://www.senestech.com
 
 • General Corporate Information   
Officers
Kenneth Siegel - Chief Executive Officer
Jamie Bechtel - Chair of the Board
Thomas C. Chesterman - Chief Financial Officer and Treasurer
Marc Dumont - Director
Delphine Francois Chiavarini - Director

Peer Information
Senestech, Inc. (BJCT)
Senestech, Inc. (CADMQ)
Senestech, Inc. (APNO)
Senestech, Inc. (UPDC)
Senestech, Inc. (IMTIQ)
Senestech, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 81720R208
SIC: 2870
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 12.21
Most Recent Split Date: 2.00 (0.05:1)
Beta: 1.38
Market Capitalization: $5.86 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.79 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.74
Price/Cash Flow: -
Price / Sales: 8.29
EPS Growth
vs. Year Ago Period: 13.64%
vs. Previous Quarter: 9.52%
Sales Growth
vs. Year Ago Period: 121.59%
vs. Previous Quarter: 15.38%
ROE
03/31/22 - -78.77
12/31/21 - -62.99
09/30/21 - -67.90
ROA
03/31/22 - -70.01
12/31/21 - -56.54
09/30/21 - -59.36
Current Ratio
03/31/22 - 9.51
12/31/21 - 11.30
09/30/21 - 14.75
Quick Ratio
03/31/22 - -
12/31/21 - 10.24
09/30/21 - 13.59
Operating Margin
03/31/22 - -1,241.73
12/31/21 - -1,378.00
09/30/21 - -1,490.15
Net Margin
03/31/22 - -1,241.73
12/31/21 - -1,378.00
09/30/21 - -1,490.15
Pre-Tax Margin
03/31/22 - -1,241.73
12/31/21 - -1,378.00
09/30/21 - -1,485.98
Book Value
03/31/22 - 0.65
12/31/21 - 0.82
09/30/21 - 1.01
Inventory Turnover
03/31/22 - 0.42
12/31/21 - 0.37
09/30/21 - 0.47
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©